---
figid: PMC3658609__nihms455196f1
figlink: /pmc/articles/PMC3658609/figure/F1/
number: Figure 1
caption: Signaling network of HER-2-mediated NF-κB activation in radio- andlor chemo-resistant
  breast cancer cells. overexpression of HER-2 firstly activates pI3K/Akt pathway
  that, in turn, activates NF-κB. Activated NF-κB then induces a group of pro-survival
  genes including cyclin B1, mitochondrial antioxidant MnSOD and importantly, the
  HER-2 gene itself, leading to the radio-and/or chemo-resistant phenotype in HER-2-positive
  cancer cells.
pmcid: PMC3658609
papertitle: HER-2 and NF-κB as the Targets for Therapy-resistant Breast Cancer.
reftext: Kazi M. Ahmed, et al. Anticancer Res. ;26(0):4235-4243.
pmc_ranked_result_index: '10632'
pathway_score: 0.9678568
filename: nihms455196f1.jpg
figtitle: Signaling network of HER-2-mediated NFKB activation in radio- andlor chemo-resistant
  breast cancer cells
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3658609__nihms455196f1.html
  '@type': Dataset
  description: Signaling network of HER-2-mediated NF-κB activation in radio- andlor
    chemo-resistant breast cancer cells. overexpression of HER-2 firstly activates
    pI3K/Akt pathway that, in turn, activates NF-κB. Activated NF-κB then induces
    a group of pro-survival genes including cyclin B1, mitochondrial antioxidant MnSOD
    and importantly, the HER-2 gene itself, leading to the radio-and/or chemo-resistant
    phenotype in HER-2-positive cancer cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - PIK3CA
  - PIK3R5
  - AKT1
  - IKBKG
  - PIK3R4
  - ERBB2
  - PIK3R6
  - PIK3CD
  - PIK3CG
  - AKT2
  - PIK3R3
  - IKBKB
  - PIK3CB
  - PTEN
  - CHUK
  - NFKB1
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: HER-2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
chemicals: []
diseases: []
---
